Gottlieb's Parting Words For US FDA: 'Be Willing To Push' For Major Policy Changes
Executive Summary
Outgoing Commissioner tells staff, “No phrase bothered me more than when I heard people say to me they didn’t want to do something important because they wanted to ‘preserve their political capital.’” FDA should not to worry about spending political capital, Gottlieb argued, because it is replenished upon accomplishing important things.
You may also be interested in...
Stephen Hahn For US FDA Commissioner: Will Academic Experience Suffice For Confirmation?
The MD Anderson Cancer Center administrator's lack of significant government administration experience may inspire questions during the confirmation process.
Gottlieb Leaves FDA With Final Thought On What To Do About Cosmetics
Addressing for the last time the House Appropriations subcommittee with FDA oversight, Commissioner Scott Gottlieb shared his vision for sharpening cosmetics oversight in the absence of significant new resources.
Gottlieb's Greatest Strength As US FDA Commissioner? Stability
Amid all the praise for his raising of FDA's profile and aggressive policy stances, Scott Gottlieb's most valuable contribution while in office may have been leaving the agency fundamentally unchanged, an important lesson for incoming Acting Commissioner Norman Sharpless.